| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| Cost of Revenue | $33K | +50.7% | -45.2% |
| Gross Profit | -$33K | -50.7% | +45.2% |
| R&D Expense | $11K | — | -72.8% |
| SG&A Expense | $838K | +107.9% | +82.4% |
| Operating Income | -$882K | -107.6% | -57.4% |
| Net Income | -$879K | -104.4% | -58.5% |
| EPS (Basic) | -$0.07 | -75.0% | -40.0% |
| EPS (Diluted) | -$0.07 | -75.0% | -40.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $0 | — | — |
| Inventory | $571K | +0.8% | -65.3% |
| Current Assets | $5.2M | +6679.5% | +2739.2% |
| Total Assets | $5.9M | +735.9% | +206.8% |
| Current Liabilities | $231K | -61.1% | +17.1% |
| Total Liabilities | $262K | -69.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.5M | — | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $6.4M | — | — |
| Free Cash Flow | -$2.5M | — | — |
| -11.8% |
| Stockholders' Equity | $5.6M | +4318.4% | +254.1% |